HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Clinical Trials

Clinical Trials

Clinical Trials are crucial steps in the process of evaluating the safety and efficacy of medical interventions, including drugs, treatments, and medical devices, before they are approved for widespread use. These trials involve rigorous testing procedures conducted on human volunteers under controlled conditions, following strict regulatory guidelines and ethical standards. Typically divided into multiple phases, clinical trials aim to systematically assess the potential benefits and risks associated with the intervention being studied. Phase I trials primarily focus on evaluating the safety and tolerability of the intervention, often involving a small number of healthy volunteers. In contrast, Phase II trials aim to gather preliminary data on the efficacy of the intervention in patients with the targeted condition. Phase III trials are larger-scale studies designed to confirm the efficacy and safety of the intervention in a diverse patient population, providing critical evidence for regulatory approval. Following regulatory approval, Phase IV trials, also known as post-marketing surveillance studies, continue to monitor the intervention's safety and effectiveness in real-world settings. Clinical trials require meticulous planning, coordination, and adherence to protocols to ensure reliable and valid results. Participation in clinical trials is voluntary, and participants must provide informed consent after receiving detailed information about the trial's objectives, procedures, and potential risks.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico

Submit your abstract Today

Watsapp